跳至主要内容
临床试验/CTRI/2019/07/020155
CTRI/2019/07/020155尚未招募不适用

Evaluation of shigru taila nasya and pippalyadigana vati in the management of vataja pratishyaya (allergic rhinitis)-A comparative clinical study

Rishikul campus1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年7月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Cured 90% relief in sign and symptoms

研究概览

简要总结

Ayurveda is an ancient system of life. On reviewing the clinical presentation from the classical ayurvedic text the sign and system of vataja pratishayaya nearly simulate with the disease Allergic Rhinitis. The present study on shigru taila and pippalyadigana vati has been taken which has its pharmacological properties like vata kapha shamak , Anuloman, Vishaghana. In study 40 patients of vataja pratishyaya will be taken in two groups 20 patient in each on the basis of inclusion and exclusion criteria and shigru taila nasya in first A group and oral administration of pippalyadigana vati with shigru taila nasya in second B group will be given. the trial duration will be 35 days.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients fullfill the diagnostic criteria based on sign and symptoms of vataja pratishyaya and allergic rhinitis Minimum 3 recurrent attack of sign and symptoms of vataja pratishyaya and allergic rhinitis.

排除标准

  • Patients suffering from chronic or acute sinusitis, rhinitis other than allergic rhinitis, other nasal pathology like DNS., polyp Patients suffering from any chronic systemic disease like Dm, HTN, tuberculosis, lower respiratory tract disease Patients who have taken any antihistaminic, mast cell stabilizer, nasal corticosteroid or any other nasal anatomic variants in nose since two weeks.

结局指标

主要结局

Cured 90% relief in sign and symptoms

时间窗: 35 days

Marked improvement 76-90%

时间窗: 35 days

No improvement less than 25%

时间窗: 35 days

Moderate improvement 51-75%

时间窗: 35 days

Mild improvement 26-59%

时间窗: 35 days

次要结局

  • aggravation of symptoms(1 month)

研究者

发起方
Rishikul campus
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验